ClinicalTrials.gov
ClinicalTrials.gov Menu

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00088192
Recruitment Status : Completed
First Posted : July 22, 2004
Last Update Posted : August 30, 2005
Sponsor:
Collaborator:
Pfizer
Information provided by:
Eyetech Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given